Trials / Active Not Recruiting
Active Not RecruitingNCT06083350
Effects of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment
A Randomized Controlled Trial of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 144 (estimated)
- Sponsor
- Xiaofan Xu · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Patients with mild cognitive impairment aged 50-80 years old were recruited in Shiyan City, Hubei Province, and divided into intervention group and placebo group. They were given yeast β-glucan capsules and starch capsules, respectively, for 6 months, in order to explore whether yeast β-glucan can improve cognitive function of patients with mild cognitive impairment by regulating gut microbiota and its metabolites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Yeast beta-glucan | Produced by Angel Yeast Co., LTD |
| DIETARY_SUPPLEMENT | Starch | Produced by Angel Yeast Co., LTD |
Timeline
- Start date
- 2023-06-27
- Primary completion
- 2024-02-05
- Completion
- 2025-06-30
- First posted
- 2023-10-16
- Last updated
- 2024-05-14
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06083350. Inclusion in this directory is not an endorsement.